hexoprenaline has been researched along with Neonatal Death in 1 studies
Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.
Neonatal Death: The death of a live-born INFANT less than 28 days of age.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leathersich, SJ | 1 |
| Vogel, JP | 1 |
| Tran, TS | 1 |
| Hofmeyr, GJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acute Tocolysis With Terbutaline vs Placebo Prior to Emergency Caesarean Delivery for Suspected Intrauterine Fetal Compromise[NCT05326269] | 100 participants (Actual) | Interventional | 2017-04-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hexoprenaline and Neonatal Death
| Article | Year |
|---|---|
Acute tocolysis for uterine tachysystole or suspected fetal distress.
Topics: Adrenergic beta-2 Receptor Agonists; Cesarean Section; Female; Fenoterol; Fetal Distress; Hexoprenal | 2018 |